1. Home
  2. HOUR vs RFL Comparison

HOUR vs RFL Comparison

Compare HOUR & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hour Loop Inc.

HOUR

Hour Loop Inc.

HOLD

Current Price

$1.98

Market Cap

63.3M

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.23

Market Cap

61.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOUR
RFL
Founded
2015
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Real Estate
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
61.1M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
HOUR
RFL
Price
$1.98
$1.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.0K
57.2K
Earning Date
02-24-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
128.57
28.28
EPS
0.07
N/A
Revenue
$138,252,861.00
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$28.14
N/A
Revenue Growth
4.64
43.96
52 Week Low
$1.10
$1.12
52 Week High
$6.84
$3.19

Technical Indicators

Market Signals
Indicator
HOUR
RFL
Relative Strength Index (RSI) 57.92 55.61
Support Level $1.73 $1.15
Resistance Level $1.95 $1.32
Average True Range (ATR) 0.08 0.06
MACD 0.02 0.01
Stochastic Oscillator 50.45 76.92

Price Performance

Historical Comparison
HOUR
RFL

About HOUR Hour Loop Inc.

Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: